Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

ATAI

ATAI Life Sciences NV (ATAI)

ATAI Life Sciences NV
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ATAI
DatumZeitQuelleÜberschriftSymbolFirma
05/03/202513h00GlobeNewswire Inc.atai Life Sciences Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003 for Treatment-Resistant DepressionNASDAQ:ATAIATAI Life Sciences NV
25/02/202503h59Edgar (US Regulatory)Form SCHEDULE 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:ATAIATAI Life Sciences NV
24/02/202522h10GlobeNewswire Inc.atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care ConferenceNASDAQ:ATAIATAI Life Sciences NV
20/02/202513h00GlobeNewswire Inc.atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common SharesNASDAQ:ATAIATAI Life Sciences NV
20/02/202500h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
13/02/202522h37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
13/02/202522h35Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ATAIATAI Life Sciences NV
13/02/202504h47GlobeNewswire Inc.atai Life Sciences Announces Pricing of Public Offering of Common SharesNASDAQ:ATAIATAI Life Sciences NV
12/02/202522h16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ATAIATAI Life Sciences NV
12/02/202522h01GlobeNewswire Inc.atai Life Sciences Announces Proposed Public Offering of Common SharesNASDAQ:ATAIATAI Life Sciences NV
28/01/202513h00GlobeNewswire Inc.atai Life Sciences Announces Positive Topline Results from Beckley Psytech’s BPL-003 (intranasal 5-MeO-DMT benzoate) Phase 2a Open-Label Study for Alcohol Use DisorderNASDAQ:ATAIATAI Life Sciences NV
24/01/202522h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
10/01/202522h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
10/01/202522h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
10/01/202522h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
10/01/202513h23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
10/01/202513h00GlobeNewswire Inc.atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental HealthNASDAQ:ATAIATAI Life Sciences NV
13/12/202422h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
13/11/202414h19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
13/11/202414h00GlobeNewswire Inc.atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:ATAIATAI Life Sciences NV
11/11/202413h30GlobeNewswire Inc.Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial OfficerNASDAQ:ATAIATAI Life Sciences NV
15/10/202414h00GlobeNewswire Inc.atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:ATAIATAI Life Sciences NV
04/10/202422h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
04/10/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
04/10/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
04/10/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
04/10/202422h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
04/09/202413h00GlobeNewswire Inc.atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ATAIATAI Life Sciences NV
14/08/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
13/08/202413h23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
 Showing the most relevant articles for your search:NASDAQ:ATAI